CCDC179
geneOn this page
Summary
CCDC179 (coiled-coil domain containing 179, HGNC:44653) is a protein-coding gene on chromosome 11p14.3, encoding Coiled-coil domain-containing protein 179 (H3BU77).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 16 total — 1 pathogenic
- MANE Select transcript:
NM_001195637
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44653 |
| Approved symbol | CCDC179 |
| Name | coiled-coil domain containing 179 |
| Location | 11p14.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000255359 |
| Ensembl biotype | protein_coding |
| Entrez | 100500938 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 retained_intron, 1 protein_coding
ENST00000529466, ENST00000532798
RefSeq mRNA: 1 — MANE Select: NM_001195637
NM_001195637
CCDS: CCDS58127
Canonical transcript exons
ENST00000532798 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002145637 | 22859452 | 22859496 |
| ENSE00002170227 | 22857922 | 22858026 |
| ENSE00002181365 | 22860377 | 22860474 |
| ENSE00002196933 | 22846922 | 22847521 |
Expression profiles
Bgee: expression breadth broad, 47 present calls, max score 90.98.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0618 / max 72.6247, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 119018 | 0.0618 | 3 |
Top tissues by expression
93 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.98 | gold quality |
| left testis | UBERON:0004533 | 90.08 | gold quality |
| testis | UBERON:0000473 | 89.35 | gold quality |
| right testis | UBERON:0004534 | 89.24 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.39 | gold quality |
| quadriceps femoris | UBERON:0001377 | 83.72 | gold quality |
| cerebellar vermis | UBERON:0004720 | 81.46 | gold quality |
| thymus | UBERON:0002370 | 78.61 | silver quality |
| calcaneal tendon | UBERON:0003701 | 49.06 | gold quality |
| granulocyte | CL:0000094 | 45.84 | silver quality |
| corpus callosum | UBERON:0002336 | 42.76 | gold quality |
| adrenal tissue | UBERON:0018303 | 42.41 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.77 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| bone marrow | UBERON:0002371 | 35.64 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| gall bladder | UBERON:0002110 | 34.46 | gold quality |
| right lung | UBERON:0002167 | 34.35 | gold quality |
| liver | UBERON:0002107 | 33.82 | silver quality |
| muscle tissue | UBERON:0002385 | 33.58 | gold quality |
| metanephros cortex | UBERON:0010533 | 32.66 | gold quality |
| urinary bladder | UBERON:0001255 | 32.29 | gold quality |
| right uterine tube | UBERON:0001302 | 32.18 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| tonsil | UBERON:0002372 | 31.39 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| lymph node | UBERON:0000029 | 30.63 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.93 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
76 targeting CCDC179, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc179 | ENSMUSG00000094445 |
| rattus_norvegicus | Ccdc179 | ENSRNOG00000049297 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 179 — H3BU77 (reviewed: H3BU77)
All UniProt accessions (1): H3BU77
RefSeq proteins (1): NP_001182566* (*=MANE)
Domains & families (InterPro)
UniProt features (5 total): compositionally biased region 2, chain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-H3BU77-F1 | 80.41 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
chr11p14, MIR548N, MIR559, MIR548AW, MIR548Y, MIR548BB_5P, MIR548AR_5P, MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P, MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P, MIR548O_5P_MIR548W, MIR548AB, MIR548AS_5P, MIR548A_5P, MIR548AQ_5P, MIR548I
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
18 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC179 | PTER | Q96BW5 | 530 |
| CCDC179 | NIBAN1 | Q9BZQ8 | 477 |
| CCDC179 | DNAH5 | Q8TE73 | 444 |
| CCDC179 | AATF | Q9NY61 | 232 |
| CCDC179 | CAPZB | P47756 | 202 |
| CCDC179 | IGF1R | P08069 | 172 |
| CCDC179 | IDH3G | P51553 | 156 |
| CCDC179 | SAMD4B | Q5PRF9 | 0 |
| CCDC179 | PPARA | Q07869 | 0 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCDC179 | SAMD4B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC179 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CCDC179 | ZNF655 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC179 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| CCDC179 | ZNF655 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): CCDC179 (Two-hybrid), CCDC179 (Two-hybrid), CCDC179 (Two-hybrid)
ESM2 similar proteins: A0A1B0GU33, A0A1B0GUV7, A6NGY3, A6ZT44, F5HHT4, G2TRR6, H3BU77, O13894, O54835, O89085, P0C2W9, P0C6G1, P0C6G2, P0C6G3, P0C6G4, P0C6G5, P0C733, P0DON5, P0DON6, P14976, P16722, P27262, P27271, P28979, P29887, P38612, P38839, Q05105, Q08588, Q1KN14, Q1KN19, Q1X6Y3, Q1X6Y4, Q1X6Z0, Q2YDL7, Q5R5R7, Q5ZK14, Q67621, Q6W0C5, Q88891
Diamond homologs: H3BU77, J3QM76
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
16 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 685359 | GRCh37/hg19 11p14.3(chr11:22619798-23441691)x1 | Pathogenic |
SpliceAI
526 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:22847522:C:CC | acceptor_gain | 1.0000 |
| 11:22857920:A:AC | donor_gain | 1.0000 |
| 11:22857921:C:CC | donor_gain | 1.0000 |
| 11:22857921:CT:C | donor_gain | 1.0000 |
| 11:22858029:T:TC | acceptor_gain | 1.0000 |
| 11:22858038:T:TC | acceptor_gain | 1.0000 |
| 11:22847519:CCA:C | acceptor_gain | 0.9900 |
| 11:22847520:CA:C | acceptor_gain | 0.9900 |
| 11:22847520:CAC:C | acceptor_gain | 0.9900 |
| 11:22847532:T:TC | acceptor_gain | 0.9900 |
| 11:22857913:TATAC:T | donor_loss | 0.9900 |
| 11:22857914:ATACT:A | donor_loss | 0.9900 |
| 11:22857915:TACTT:T | donor_loss | 0.9900 |
| 11:22857916:AC:A | donor_loss | 0.9900 |
| 11:22857917:C:G | donor_loss | 0.9900 |
| 11:22857918:T:TA | donor_loss | 0.9900 |
| 11:22857919:TACT:T | donor_loss | 0.9900 |
| 11:22857920:ACT:A | donor_loss | 0.9900 |
| 11:22857921:CTA:C | donor_gain | 0.9900 |
| 11:22857921:CTAG:C | donor_gain | 0.9900 |
| 11:22857921:CTAGG:C | donor_gain | 0.9900 |
| 11:22857955:TGAAA:T | donor_gain | 0.9900 |
| 11:22858023:CAAG:C | acceptor_gain | 0.9900 |
| 11:22858025:AGCT:A | acceptor_loss | 0.9900 |
| 11:22858027:C:CC | acceptor_gain | 0.9900 |
| 11:22858028:T:C | acceptor_gain | 0.9900 |
| 11:22858029:T:C | acceptor_gain | 0.9900 |
| 11:22858038:T:C | acceptor_gain | 0.9900 |
| 11:22860375:A:AC | donor_gain | 0.9900 |
| 11:22860376:C:CC | donor_gain | 0.9900 |
AlphaMissense
436 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:22857958:A:C | F53L | 0.953 |
| 11:22857958:A:T | F53L | 0.953 |
| 11:22857960:A:G | F53L | 0.953 |
| 11:22857979:C:A | K46N | 0.884 |
| 11:22857979:C:G | K46N | 0.884 |
| 11:22858013:C:G | R35P | 0.883 |
| 11:22857992:A:G | L42P | 0.875 |
| 11:22857959:A:G | F53S | 0.870 |
| 11:22858010:A:G | I36T | 0.855 |
| 11:22857971:A:G | L49P | 0.840 |
| 11:22857964:T:A | K51N | 0.831 |
| 11:22857964:T:G | K51N | 0.831 |
| 11:22857959:A:C | F53C | 0.823 |
| 11:22858010:A:C | I36S | 0.810 |
| 11:22857965:T:A | K51I | 0.768 |
| 11:22858001:A:G | M39T | 0.753 |
| 11:22860416:G:C | C2W | 0.738 |
| 11:22857985:T:A | K44N | 0.732 |
| 11:22857985:T:G | K44N | 0.732 |
| 11:22860418:A:G | C2R | 0.726 |
| 11:22857986:T:A | K44I | 0.722 |
| 11:22857930:C:G | G63R | 0.720 |
| 11:22857930:C:T | G63R | 0.720 |
| 11:22857980:T:G | K46T | 0.710 |
| 11:22858014:G:T | R35S | 0.694 |
| 11:22857988:C:A | K43N | 0.689 |
| 11:22857988:C:G | K43N | 0.689 |
| 11:22858010:A:T | I36N | 0.687 |
| 11:22857960:A:C | F53V | 0.685 |
| 11:22857926:A:G | L64P | 0.680 |
dbSNP variants (sampled 300 via entrez): RS1000005473 (11:22849978 C>T), RS1000413575 (11:22858461 C>G), RS1000427996 (11:22856120 A>G), RS1000695709 (11:22861054 T>C), RS1000947447 (11:22850168 C>A), RS1001163142 (11:22854663 A>G), RS1001618835 (11:22853526 A>G), RS1001677050 (11:22848893 T>C), RS1001689681 (11:22859778 G>A), RS1002005851 (11:22847767 A>T), RS1002109472 (11:22859980 T>C), RS1002256707 (11:22853472 G>A,T), RS1002363497 (11:22859823 T>C,G), RS1002565848 (11:22847815 A>G), RS1002793831 (11:22858959 A>G)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:600057
GenCC curated gene-disease
Mondo (1): bladder exstrophy-epispadias-cloacal exstrophy complex (MONDO:0700039)
Orphanet (1): Classic bladder exstrophy (Orphanet:93930)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009997_8 | Thyroid volume in Hashimoto’s thyroiditis | 7.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bladder exstrophy-epispadias-cloacal exstrophy complex